In an elegant fusion of art and science, researchers at Rice University have achieved a major milestone in nanomaterials ...

As the number of particles in a physical system increases, its properties can change and different phase transitions (i.e., ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to ...

SINGAPORE – In a more advanced economy and with a better-educated population, the SkillsFuture movement must do better in curating courses and helping Singaporeans identify those that will ...